BioSpace News Archive

Business

Chengdu’s NetVation DL Forms Partnership With Pfizer

NetVation DL Medicine, a privately held Chengdu biotech, has entered a two-year research collaboration with Pfizer.

February 7, 2018

·

1 min read

China’s Luqa Pharma Closes $15M B Round for Dermatology/Aesthetic Products

Luqa Pharma of Hong Kong closed a $15M Series B financing round led by Cenova Capital.

February 7, 2018

·

1 min read

Business

Jing Medicine Forms $100 Million Collaboration with ShanghaiTech University

Jing Medicine Technology will collaborate with ShanghaiTech University in a $100M partnership to discover and develop novel small molecule cancer drugs.

February 7, 2018

·

1 min read

Gilead's $12B Bet Pays Off in Two Months After the

FDA

Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy.

February 7, 2018

·

2 min read

·

Mark Terry

SCHOTT AG, ARaymondlife and Vanrx Pharmasystems Announce Product Compatibility for Primary Packaging of Sterile Injectables

This Product Set is fully commercially available and ready-to-use, with closure integrity performance results available from the suppliers.

February 7, 2018

·

4 min read

Biotech Bay

Anpac Bio’s Liquid Biopsy Tests Catch 26+ Early-Stage Cancers in Single Blood Test!

Anpac and its internationally-acclaimed medical research partners, are celebrating “National Cancer Prevention Day” by confirming a new, global milestone.

February 7, 2018

·

5 min read

Biotech Beach

Innovus Pharma Announces the Publication of a Successful Clinical Trial in Overactive Bladder and Urine Incontinence Patients for its UriVarx Product

Innovus Pharma announced that the human clinical trial for the patented formulation in its product UriVarx product for bladder health was published in the peer reviewed journal, BMC Complementary and Alternative Medicine (Schoendorfer et al. BMC Complementary and Alternative Medicine (2018) 18:42).

February 7, 2018

·

4 min read

On a Roll: Sage Shows Off Early-Stage Insomnia Dat

Drug Development

On a Roll: FDA Calls Sage’s Depression Drug a Breakthrough

This is the second Breakthrough Therapy designation granted to Sage since 2016.

February 7, 2018

·

6 min read

China Cord Blood Corporation to Change Corporate Name to “Global Cord Blood Corporation”

The Board believes that the Change of Name better reflects the future development direction and business strategy of the Company.

February 7, 2018

·

2 min read

Appili Therapeutics Raises an Additional $4.3 Million in Oversubscribed Financing to Advance its Anti-infective Pipeline

Appili Therapeutics today it raised an additional $4,339,000 in an oversubscribed private placement financing, bringing the total equity raised since its seed round in March 2016 to $11,816,000.

February 7, 2018

·

3 min read